There was a time when if you were diagnosed with acute promyelocytic leukemia, or APL, the prognosis was grim. First discovered in 1957, APL is a form of acute myeloid leukemia, where immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a…...
Changing the Way Drugs Target Cancer
Cancer treatment has evolved greatly in the past fifty years. Since the introduction of chemotherapy, radiation therapy and stem cell transplants, tens of thousands of cancer patients have been victorious in battle. All of these advances have impacted cancer treatment, but a recent drug approval by the U.S. Food and…...
Head and Neck Cancer Awareness Month: Possible Link to Mental Health Disorders
Accounting for approximately 3% of cancer cases nationwide, the symptoms of head and neck cancer are particularly uncomfortable. Head and neck cancer refers to tumors that develop around the throat, larynx, nose, sinus and mouth. As these areas support vital bodily functions, such as eating and breathing, the symptoms can…...
NFCR Fellow Susan Band Horwitz Receives Canada Gairdner Award
FOR IMMEDIATE RELEASE: April 2, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Canada’s Most Prominent Scientific Prize Honors World’s Biomedical Research Elite ROCKVILLE, MD – Susan Band Horwitz, Ph.D., has today been named one of seven…...
NFCR at the 2019 American Association for Cancer Research Annual Meeting
FOR IMMEDIATE RELEASE: March 28, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Profile Includes Distinguished Public Service Award for Daniel Von Hoff ROCKVILLE, MD – The National Foundation for Cancer Research (NFCR) will be well represented…...
Carlo Croce: It’s All About (Trans)Location
“It was a great pleasure because it is so important,” recalls Carlo Croce, M.D., of his 2008 win of the National Foundation for Cancer Research’s Szent-Györgyi Prize for Progress in Cancer Research. “The committee is very selective, and they really want to choose outstanding people who really have made a…...










